Nisa Investment Advisors
DFTX

Nisa Investment Advisors’s Definium Therapeutics DFTX Stock Holding History

Nisa Investment Advisors’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$924K Buy
48,903
+525
+1% +$8.91K ﹤0.01% 807
2025
Q4 		$648K Hold
48,378
– – ﹤0.01% 932
2025
Q3 		$570K Buy
48,378
+45,000
+1,332% +$420K ﹤0.01% 986
2025
Q2 		$21.9K Buy
3,378
+945
+39% +$6.21K ﹤0.01% 1892
2025
Q1 		$14.2K Buy
2,433
+2,229
+1,093% +$16K ﹤0.01% 2011
2024
Q4 		$1.42K Buy
+204
New +$1.4K ﹤0.01% 2585
2022
Q2 		– Sell
-1,463
Closed -$24K – 2457
2022
Q1 		$24K Buy
+1,463
New +$25.4K ﹤0.01% 2018

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nisa Investment Advisors's DFTX Position: Q1 2026 in Review

Nisa Investment Advisors increased its Definium Therapeutics (DFTX) stake by 1.1% in Q1 2026, buying an estimated $8.91K and bringing the position to 48,903 shares worth $924K. The position accounts for ﹤0.01% of the portfolio, ranked #807.

Nisa Investment Advisors first reported a position in DFTX in Q1 2022 and has held it in 7 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Nisa Investment Advisors held 48,903 shares of Definium Therapeutics worth $924K as of Q1 2026.
  • Nisa Investment Advisors bought 525 Definium Therapeutics shares in Q1 2026, an estimated $8.91K.
  • Definium Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #807 holding.
  • Nisa Investment Advisors first reported a position in Definium Therapeutics in Q1 2022 and has held it in 7 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.